GetTopicDetailResponse(id=07352693681, topicName=依達拉奉, introduction=依達拉奉, content=null, image=null, comments=2, allHits=2013, url=https://h5.medsci.cn/topic?id=26936, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=26229, tagList=[TagDto(tagId=26229, tagName=依達拉奉)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2172049, encodeId=389d21e2049c8, content=<a href='/topic/show?id=eb418106018' target=_blank style='color:#2F92EE;'>#肌萎縮側(cè)索硬化癥#</a> <a href='/topic/show?id=07352693681' target=_blank style='color:#2F92EE;'>#依達拉奉#</a>, objectTitle=2023AANEM：依達拉奉對肌萎縮側(cè)索硬化癥病程的影響, objectType=article, longId=802978, objectId=73438029e8e3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20231130/1701276120696_2291021.jpg, objectUrl=/article/show_article.do?id=73438029e8e3, replyNumber=0, likeNumber=130, createdTime=2023-11-30, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=73438029e8e3, moduleTitle=2023AANEM：依達拉奉對肌萎縮側(cè)索硬化癥病程的影響, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=73438029e8e3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1185271, encodeId=c8ae11852e11e, content=<a href='/topic/show?id=07352693681' target=_blank style='color:#2F92EE;'>#依達拉奉#</a>對<a href='/topic/show?id=2b2d66280da' target=_blank style='color:#2F92EE;'>#漸凍人#</a>本來作用就很弱的哦, objectTitle=JAMA子刊：卒中藥物依達拉奉治療“漸凍人”患者安全性可靠而有效性存疑, objectType=article, longId=294139, objectId=9156294139ae, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2022117/1642397908534_2299762.jpg, objectUrl=/article/show_article.do?id=9156294139ae, replyNumber=0, likeNumber=192, createdTime=2022-01-17, rootId=0, userName=病毒獵手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9156294139ae, moduleTitle=JAMA子刊：卒中藥物依達拉奉治療“漸凍人”患者安全性可靠而有效性存疑, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9156294139ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=882402, encodeId=82108824021c, content=<a href='/topic/show?id=4d358106593' target=_blank style='color:#2F92EE;'>#肌萎縮性側(cè)索硬化癥#</a>估計VitC，VitE，或其它抗氧化劑都有用！但是，事實上根本不解決根本問題。以前FDA批準了<a href='/topic/show?id=07352693681' target=_blank style='color:#2F92EE;'>#依達拉奉#</a>治療這個疾病，其實作用是十分微弱的。苯丁酸鈉-?；嵌纪瑯尤绱? objectTitle=NEJM：苯丁酸鈉-牛磺二醇治療肌萎縮性側(cè)索硬化癥的療效分析, objectType=article, longId=200187, objectId=cd2520018ecd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202093/1599092574157_1739456.jpg, objectUrl=/article/show_article.do?id=cd2520018ecd, replyNumber=0, likeNumber=223, createdTime=2020-09-03, rootId=0, userName=1381abdab4m, userId=f0f41699279, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd2520018ecd, moduleTitle=NEJM：苯丁酸鈉-?；嵌贾委熂∥s性側(cè)索硬化癥的療效分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=cd2520018ecd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
